Answers are grounded in this paper and cite their sources.
VHD trials have expanded in scale and scope with increased trial-level mean age. However, persistent sex disparities and demographic variability highlight the need for more inclusive trial designs to guide equitable valve therapy.
No takes yet. Share an insight, caveat, or question.
Rivera et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: